Global Nivolumab Injection Market Growth 2023-2029

March 2023 | 95 pages | ID: G5FC9B90E2D1EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Nivolumab Injection is suitable for treating adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are negative for mutations in the epidermal growth factor receptor (EGFR) gene and negative for anaplastic lymphoma kinase (ALK), who have previously undergone platinum-containing chemotherapy and whose disease has progressed or is intolerable.

LPI (LP Information)' newest research report, the “Nivolumab Injection Industry Forecast” looks at past sales and reviews total world Nivolumab Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Nivolumab Injection sales for 2023 through 2029. With Nivolumab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nivolumab Injection industry.

This Insight Report provides a comprehensive analysis of the global Nivolumab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nivolumab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nivolumab Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nivolumab Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nivolumab Injection.

The global Nivolumab Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Nivolumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Nivolumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Nivolumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Nivolumab Injection players cover AbbVie, Allergan, Ono Pharmaceutical, Sinopharm and Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Nivolumab Injection market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 100IU
• 50IU
• Other

Segmentation by application

• Unresectable Melanoma
• Metastatic Melanoma
• Metastatic Squamous NSCLC
• Classical Hodgkin Lymphoma
• Renal Cell Carcinoma
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AbbVie
• Allergan
• Ono Pharmaceutical
• Sinopharm
• Bristol-Myers Squibb

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nivolumab Injection market?

What factors are driving Nivolumab Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nivolumab Injection market opportunities vary by end market size?

How does Nivolumab Injection break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nivolumab Injection Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Nivolumab Injection by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Nivolumab Injection by Country/Region, 2018, 2022 & 2029
2.2 Nivolumab Injection Segment by Type
  2.2.1 100IU
  2.2.2 50IU
  2.2.3 Other
2.3 Nivolumab Injection Sales by Type
  2.3.1 Global Nivolumab Injection Sales Market Share by Type (2018-2023)
  2.3.2 Global Nivolumab Injection Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Nivolumab Injection Sale Price by Type (2018-2023)
2.4 Nivolumab Injection Segment by Application
  2.4.1 Unresectable Melanoma
  2.4.2 Metastatic Melanoma
  2.4.3 Metastatic Squamous NSCLC
  2.4.4 Classical Hodgkin Lymphoma
  2.4.5 Renal Cell Carcinoma
  2.4.6 Other
2.5 Nivolumab Injection Sales by Application
  2.5.1 Global Nivolumab Injection Sale Market Share by Application (2018-2023)
  2.5.2 Global Nivolumab Injection Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Nivolumab Injection Sale Price by Application (2018-2023)

3 GLOBAL NIVOLUMAB INJECTION BY COMPANY

3.1 Global Nivolumab Injection Breakdown Data by Company
  3.1.1 Global Nivolumab Injection Annual Sales by Company (2018-2023)
  3.1.2 Global Nivolumab Injection Sales Market Share by Company (2018-2023)
3.2 Global Nivolumab Injection Annual Revenue by Company (2018-2023)
  3.2.1 Global Nivolumab Injection Revenue by Company (2018-2023)
  3.2.2 Global Nivolumab Injection Revenue Market Share by Company (2018-2023)
3.3 Global Nivolumab Injection Sale Price by Company
3.4 Key Manufacturers Nivolumab Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Nivolumab Injection Product Location Distribution
  3.4.2 Players Nivolumab Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR NIVOLUMAB INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Nivolumab Injection Market Size by Geographic Region (2018-2023)
  4.1.1 Global Nivolumab Injection Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Nivolumab Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nivolumab Injection Market Size by Country/Region (2018-2023)
  4.2.1 Global Nivolumab Injection Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Nivolumab Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nivolumab Injection Sales Growth
4.4 APAC Nivolumab Injection Sales Growth
4.5 Europe Nivolumab Injection Sales Growth
4.6 Middle East & Africa Nivolumab Injection Sales Growth

5 AMERICAS

5.1 Americas Nivolumab Injection Sales by Country
  5.1.1 Americas Nivolumab Injection Sales by Country (2018-2023)
  5.1.2 Americas Nivolumab Injection Revenue by Country (2018-2023)
5.2 Americas Nivolumab Injection Sales by Type
5.3 Americas Nivolumab Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nivolumab Injection Sales by Region
  6.1.1 APAC Nivolumab Injection Sales by Region (2018-2023)
  6.1.2 APAC Nivolumab Injection Revenue by Region (2018-2023)
6.2 APAC Nivolumab Injection Sales by Type
6.3 APAC Nivolumab Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Nivolumab Injection by Country
  7.1.1 Europe Nivolumab Injection Sales by Country (2018-2023)
  7.1.2 Europe Nivolumab Injection Revenue by Country (2018-2023)
7.2 Europe Nivolumab Injection Sales by Type
7.3 Europe Nivolumab Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nivolumab Injection by Country
  8.1.1 Middle East & Africa Nivolumab Injection Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Nivolumab Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Nivolumab Injection Sales by Type
8.3 Middle East & Africa Nivolumab Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nivolumab Injection
10.3 Manufacturing Process Analysis of Nivolumab Injection
10.4 Industry Chain Structure of Nivolumab Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Nivolumab Injection Distributors
11.3 Nivolumab Injection Customer

12 WORLD FORECAST REVIEW FOR NIVOLUMAB INJECTION BY GEOGRAPHIC REGION

12.1 Global Nivolumab Injection Market Size Forecast by Region
  12.1.1 Global Nivolumab Injection Forecast by Region (2024-2029)
  12.1.2 Global Nivolumab Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nivolumab Injection Forecast by Type
12.7 Global Nivolumab Injection Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 AbbVie
  13.1.1 AbbVie Company Information
  13.1.2 AbbVie Nivolumab Injection Product Portfolios and Specifications
  13.1.3 AbbVie Nivolumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 AbbVie Main Business Overview
  13.1.5 AbbVie Latest Developments
13.2 Allergan
  13.2.1 Allergan Company Information
  13.2.2 Allergan Nivolumab Injection Product Portfolios and Specifications
  13.2.3 Allergan Nivolumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Allergan Main Business Overview
  13.2.5 Allergan Latest Developments
13.3 Ono Pharmaceutical
  13.3.1 Ono Pharmaceutical Company Information
  13.3.2 Ono Pharmaceutical Nivolumab Injection Product Portfolios and Specifications
  13.3.3 Ono Pharmaceutical Nivolumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Ono Pharmaceutical Main Business Overview
  13.3.5 Ono Pharmaceutical Latest Developments
13.4 Sinopharm
  13.4.1 Sinopharm Company Information
  13.4.2 Sinopharm Nivolumab Injection Product Portfolios and Specifications
  13.4.3 Sinopharm Nivolumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Sinopharm Main Business Overview
  13.4.5 Sinopharm Latest Developments
13.5 Bristol-Myers Squibb
  13.5.1 Bristol-Myers Squibb Company Information
  13.5.2 Bristol-Myers Squibb Nivolumab Injection Product Portfolios and Specifications
  13.5.3 Bristol-Myers Squibb Nivolumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Bristol-Myers Squibb Main Business Overview
  13.5.5 Bristol-Myers Squibb Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nivolumab Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nivolumab Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 100IU
Table 4. Major Players of 50IU
Table 5. Major Players of Other
Table 6. Global Nivolumab Injection Sales by Type (2018-2023) & (K Units)
Table 7. Global Nivolumab Injection Sales Market Share by Type (2018-2023)
Table 8. Global Nivolumab Injection Revenue by Type (2018-2023) & ($ million)
Table 9. Global Nivolumab Injection Revenue Market Share by Type (2018-2023)
Table 10. Global Nivolumab Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Nivolumab Injection Sales by Application (2018-2023) & (K Units)
Table 12. Global Nivolumab Injection Sales Market Share by Application (2018-2023)
Table 13. Global Nivolumab Injection Revenue by Application (2018-2023)
Table 14. Global Nivolumab Injection Revenue Market Share by Application (2018-2023)
Table 15. Global Nivolumab Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Nivolumab Injection Sales by Company (2018-2023) & (K Units)
Table 17. Global Nivolumab Injection Sales Market Share by Company (2018-2023)
Table 18. Global Nivolumab Injection Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Nivolumab Injection Revenue Market Share by Company (2018-2023)
Table 20. Global Nivolumab Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Nivolumab Injection Producing Area Distribution and Sales Area
Table 22. Players Nivolumab Injection Products Offered
Table 23. Nivolumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Nivolumab Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Nivolumab Injection Sales Market Share Geographic Region (2018-2023)
Table 28. Global Nivolumab Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Nivolumab Injection Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Nivolumab Injection Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Nivolumab Injection Sales Market Share by Country/Region (2018-2023)
Table 32. Global Nivolumab Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Nivolumab Injection Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Nivolumab Injection Sales by Country (2018-2023) & (K Units)
Table 35. Americas Nivolumab Injection Sales Market Share by Country (2018-2023)
Table 36. Americas Nivolumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Nivolumab Injection Revenue Market Share by Country (2018-2023)
Table 38. Americas Nivolumab Injection Sales by Type (2018-2023) & (K Units)
Table 39. Americas Nivolumab Injection Sales by Application (2018-2023) & (K Units)
Table 40. APAC Nivolumab Injection Sales by Region (2018-2023) & (K Units)
Table 41. APAC Nivolumab Injection Sales Market Share by Region (2018-2023)
Table 42. APAC Nivolumab Injection Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Nivolumab Injection Revenue Market Share by Region (2018-2023)
Table 44. APAC Nivolumab Injection Sales by Type (2018-2023) & (K Units)
Table 45. APAC Nivolumab Injection Sales by Application (2018-2023) & (K Units)
Table 46. Europe Nivolumab Injection Sales by Country (2018-2023) & (K Units)
Table 47. Europe Nivolumab Injection Sales Market Share by Country (2018-2023)
Table 48. Europe Nivolumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Nivolumab Injection Revenue Market Share by Country (2018-2023)
Table 50. Europe Nivolumab Injection Sales by Type (2018-2023) & (K Units)
Table 51. Europe Nivolumab Injection Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Nivolumab Injection Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Nivolumab Injection Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Nivolumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Nivolumab Injection Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Nivolumab Injection Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Nivolumab Injection Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Nivolumab Injection
Table 59. Key Market Challenges & Risks of Nivolumab Injection
Table 60. Key Industry Trends of Nivolumab Injection
Table 61. Nivolumab Injection Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Nivolumab Injection Distributors List
Table 64. Nivolumab Injection Customer List
Table 65. Global Nivolumab Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Nivolumab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Nivolumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Nivolumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Nivolumab Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Nivolumab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Nivolumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Nivolumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Nivolumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Nivolumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Nivolumab Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Nivolumab Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Nivolumab Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Nivolumab Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. AbbVie Basic Information, Nivolumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 80. AbbVie Nivolumab Injection Product Portfolios and Specifications
Table 81. AbbVie Nivolumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. AbbVie Main Business
Table 83. AbbVie Latest Developments
Table 84. Allergan Basic Information, Nivolumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 85. Allergan Nivolumab Injection Product Portfolios and Specifications
Table 86. Allergan Nivolumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Allergan Main Business
Table 88. Allergan Latest Developments
Table 89. Ono Pharmaceutical Basic Information, Nivolumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 90. Ono Pharmaceutical Nivolumab Injection Product Portfolios and Specifications
Table 91. Ono Pharmaceutical Nivolumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Ono Pharmaceutical Main Business
Table 93. Ono Pharmaceutical Latest Developments
Table 94. Sinopharm Basic Information, Nivolumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Sinopharm Nivolumab Injection Product Portfolios and Specifications
Table 96. Sinopharm Nivolumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Sinopharm Main Business
Table 98. Sinopharm Latest Developments
Table 99. Bristol-Myers Squibb Basic Information, Nivolumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. Bristol-Myers Squibb Nivolumab Injection Product Portfolios and Specifications
Table 101. Bristol-Myers Squibb Nivolumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Bristol-Myers Squibb Main Business
Table 103. Bristol-Myers Squibb Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Nivolumab Injection
Figure 2. Nivolumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nivolumab Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Nivolumab Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nivolumab Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 100IU
Figure 10. Product Picture of 50IU
Figure 11. Product Picture of Other
Figure 12. Global Nivolumab Injection Sales Market Share by Type in 2022
Figure 13. Global Nivolumab Injection Revenue Market Share by Type (2018-2023)
Figure 14. Nivolumab Injection Consumed in Unresectable Melanoma
Figure 15. Global Nivolumab Injection Market: Unresectable Melanoma (2018-2023) & (K Units)
Figure 16. Nivolumab Injection Consumed in Metastatic Melanoma
Figure 17. Global Nivolumab Injection Market: Metastatic Melanoma (2018-2023) & (K Units)
Figure 18. Nivolumab Injection Consumed in Metastatic Squamous NSCLC
Figure 19. Global Nivolumab Injection Market: Metastatic Squamous NSCLC (2018-2023) & (K Units)
Figure 20. Nivolumab Injection Consumed in Classical Hodgkin Lymphoma
Figure 21. Global Nivolumab Injection Market: Classical Hodgkin Lymphoma (2018-2023) & (K Units)
Figure 22. Nivolumab Injection Consumed in Renal Cell Carcinoma
Figure 23. Global Nivolumab Injection Market: Renal Cell Carcinoma (2018-2023) & (K Units)
Figure 24. Nivolumab Injection Consumed in Other
Figure 25. Global Nivolumab Injection Market: Other (2018-2023) & (K Units)
Figure 26. Global Nivolumab Injection Sales Market Share by Application (2022)
Figure 27. Global Nivolumab Injection Revenue Market Share by Application in 2022
Figure 28. Nivolumab Injection Sales Market by Company in 2022 (K Units)
Figure 29. Global Nivolumab Injection Sales Market Share by Company in 2022
Figure 30. Nivolumab Injection Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Nivolumab Injection Revenue Market Share by Company in 2022
Figure 32. Global Nivolumab Injection Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Nivolumab Injection Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Nivolumab Injection Sales 2018-2023 (K Units)
Figure 35. Americas Nivolumab Injection Revenue 2018-2023 ($ Millions)
Figure 36. APAC Nivolumab Injection Sales 2018-2023 (K Units)
Figure 37. APAC Nivolumab Injection Revenue 2018-2023 ($ Millions)
Figure 38. Europe Nivolumab Injection Sales 2018-2023 (K Units)
Figure 39. Europe Nivolumab Injection Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Nivolumab Injection Sales 2018-2023 (K Units)
Figure 41. Middle East & Africa Nivolumab Injection Revenue 2018-2023 ($ Millions)
Figure 42. Americas Nivolumab Injection Sales Market Share by Country in 2022
Figure 43. Americas Nivolumab Injection Revenue Market Share by Country in 2022
Figure 44. Americas Nivolumab Injection Sales Market Share by Type (2018-2023)
Figure 45. Americas Nivolumab Injection Sales Market Share by Application (2018-2023)
Figure 46. United States Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Nivolumab Injection Sales Market Share by Region in 2022
Figure 51. APAC Nivolumab Injection Revenue Market Share by Regions in 2022
Figure 52. APAC Nivolumab Injection Sales Market Share by Type (2018-2023)
Figure 53. APAC Nivolumab Injection Sales Market Share by Application (2018-2023)
Figure 54. China Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Nivolumab Injection Sales Market Share by Country in 2022
Figure 62. Europe Nivolumab Injection Revenue Market Share by Country in 2022
Figure 63. Europe Nivolumab Injection Sales Market Share by Type (2018-2023)
Figure 64. Europe Nivolumab Injection Sales Market Share by Application (2018-2023)
Figure 65. Germany Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Nivolumab Injection Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Nivolumab Injection Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Nivolumab Injection Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa Nivolumab Injection Sales Market Share by Application (2018-2023)
Figure 74. Egypt Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Nivolumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Nivolumab Injection in 2022
Figure 80. Manufacturing Process Analysis of Nivolumab Injection
Figure 81. Industry Chain Structure of Nivolumab Injection
Figure 82. Channels of Distribution
Figure 83. Global Nivolumab Injection Sales Market Forecast by Region (2024-2029)
Figure 84. Global Nivolumab Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Nivolumab Injection Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global Nivolumab Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global Nivolumab Injection Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Nivolumab Injection Revenue Market Share Forecast by Application (2024-2029)